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Abstract
 
Ingestion of opsonized pathogens by professional phagocytes results in the generation and re-
lease of microbicidal products that are essential for normal host defense. Because these products
can result in significant tissue injury, phagocytosis must be regulated to limit damage to the host
while allowing for optimal clearance and destruction of opsonized pathogens. To pursue nega-
tive regulation of phagocytosis, we assessed the effect of the Src kinase family member, Fgr, on
opsonin-dependent phagocytosis by mouse macrophages. We chose Fgr because it is present in
high concentrations in circulating phagocytes but is not essential for Fc
 
g 
 
receptor–mediated in-
gestion by mouse macrophages. Although expression of Fgr both in a macrophage cell line and
in primary macrophages significantly attenuates ingestion mediated by Fc
 
g
 
 receptors and CR3,
it does not affect macropinocytosis or receptor-mediated endocytosis. This selective effect of
Fgr is independent of its tyrosine kinase function. After Fc
 
g
 
 receptor cross-linking, Fgr becomes
associated with the immunoreceptor tyrosine-based inhibition motif (ITIM)–containing recep-
tor, SIRP
 
a
 
 (a member of the signal-regulatory protein family, also known as Src homology 2
domain–containing protein tyrosine phosphatase [SHP] substrate 1 [SHPS-1], brain immuno-
globulin-like molecule with tyrosine-based activation motifs [BIT], and P84) and potentiates the
association of the phosphatase SHP-1 with SIRP
 
a
 
. This association is responsible, at least in part,
for decreasing positive signaling essential for optimal phagocytosis. These data demonstrate an im-
portant negative regulatory role for this Src kinase family member and suggest that this homeo-
static function must be overcome for optimal uptake and clearance of opsonized pathogens.
Key words: phagocytes • Src family kinases • protein tyrosine phosphatase
 
Introduction
 
Phagocytosis is a complex biological process of specialized
cells that is essential for normal host defense against infec-
tious pathogens and for resolution of tissue injury at sites of
inflammation (1–3). We and others have hypothesized that
phagocytosis is primarily a recruited function at sites of in-
fection and inflammation because ingestion mediated by
both Fc
 
g
 
 and complement receptors is augmented by in-
flammatory mediators and matrix proteins that abound at sites
of tissue injury (2, 4–9). These data imply that phagocytosis
is regulated. Regulatory control of phagocytosis would be
of substantial benefit to the host because the production of
tissue-damaging products generated during ingestion of op-
sonized pathogens, such as reactive oxygen and nitrogen
intermediates and lysosomal enzymes, would be restricted
to the site of inflammation. In this paradigm, phagocytes
circulating in the vasculature would have limited phago-
cytic potential. However, after migration into sites of in-
fection or inflammation, their phagocytic responses would
be amplified, allowing for optimal ingestion and destruc-
tion of opsonized targets. This amplification could occur by
acquiring the ability to recruit additional positive signaling
molecules and/or by losing or overcoming negative signal-
ing components that act to limit or attenuate phagocytic
responses. Although considerable advances have been made
in elucidating the intracellular signals essential for positive
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signaling in phagocytosis (1–3), knowledge of the specific
signal transduction components that negatively regulate
phagocytosis is somewhat lacking.
Negative regulation of signal transduction cascades is
necessary for homeostasis in a variety of systems. In hema-
topoietic and immune system cells, failure to regulate signal
transduction during cell activation can result in hyperre-
sponsive states that lead to significant pathological sequelae,
such as autoimmunity and excessive inflammation (10–17).
Examples include the autoimmune-mediated tissue injury
and uncontrolled leukocyte activation that occur in mice
with disrupted genes encoding the antiinflammatory cyto-
kines, IL-10 (13) and TGF-
 
b
 
1 (14–16), and the enhanced
antibody and anaphylactic responses observed in mice that
lack an inhibitory Fc
 
g
 
RIIB receptor expressed by B cells
and mast cells (11, 12). These and other examples clearly
demonstrate the importance of diminishing or terminating
activation signals to limit tissue injury. Because the hyper-
responsive states that result from failed regulation mimic sev-
eral human diseases (11, 14, 17), understanding the molecu-
lar basis of negative signaling is increasing in importance.
To pursue negative regulation of phagocytosis, we looked
for intracellular signaling molecules that would be ex-
pressed primarily if not exclusively in phagocytes and for
which essential roles in positive signaling for phagocytosis
had been eliminated. One such molecule is the Src kinase
family member, Fgr. The highest concentrations of Fgr are
found in mature granulocytes and monocytes, and its con-
centration increases with the induction of cell maturation
(18–20). In addition, Fgr coimmunoprecipitates with a phago-
cytic receptor, Fc
 
g
 
RII, in immune complex–stimulated
neutrophils (21). However, bone marrow macrophages
from mice that lack 
 
c-fgr
 
 by targeted gene disruption are
fully able to ingest IgG-opsonized targets (22). These data
suggest that Fgr is recruited to domains where phagocytic
receptors cluster and where phagocytic responses are initi-
ated but that it is not essential for ingestion to occur.
Therefore, the purpose of this work is to test the hypothesis
that Fgr is involved in negative regulation of phagocytosis.
We show that expression of Fgr attenuates phagocytosis
mediated by multiple receptors and that the suppression
occurs proximal to the reorganization of the actin cytoskel-
eton into phagocytic cups. The molecular mechanism for
this regulation involves, at least in part, the ability of Fgr
to recruit increased tyrosine phosphatase activity and the
phosphatase Src homology (SH)
 
1
 
 2 domain–containing
protein tyrosine phosphatase (SHP)-1 to a transmembrane
immunoreceptor tyrosine-based inhibition motif (ITIM)-
containing receptor, signal regulatory protein of the 
 
a
 
 sub-
type (SIRP
 
a
 
), after phagocytic receptor activation.
 
Materials and Methods
 
Reagents. 
 
The following reagents were obtained as indi-
cated: S-S.1 hybridoma, which secretes murine mAb IgG2a anti–
sheep erythrocyte (EIgG2a; American Type Culture Collection),
tissue culture supernatant containing murine mAb IgG2b anti–
sheep erythrocyte (EIgG2b; Accurate Chemical), purified rabbit
polyclonal anti–sheep erythrocyte (Diamedix), purified biotin-
labeled goat anti–rat F(ab)
 
9
 
2
 
 (Jackson ImmunoResearch Labs),
purified mAb 2.4G2 rat anti–murine Fc
 
g
 
RII/Fc
 
g
 
RIII (PharMin-
gen), purified mAb M1/70 rat anti–murine CD11b (PharMingen),
purified mAb rat IgG1 anti–murine CD14 (PharMingen), FITC-
avidin (PharMingen), purified mAb 2E6 hamster anti–murine 
 
b
 
2
 
(Endogen), FITC-labeled 70-kD dextran (Molecular Probes),
rhodamine-phalloidin (Molecular Probes), and purified murine
fibronectin (Calbiochem). Rat IgG1 anti–murine SIRP
 
a
 
 (P84
antigen [23]) was purified from tissue culture supernatant by am-
monium sulfate precipitation and protein G chromatography us-
ing the mAb Trap II kit (Amersham Pharmacia Biotech).
 
Retroviral Infections.
 
BAC1.2F5, a subclone of a murine mac-
rophage cell line (24) that does not express Fgr, was used for the
introduction of wild-type and site-directed mutants of murine
 
 c-fgr
 
by retroviral-mediated gene transfer. Murine 
 
c-fgr
 
 cDNA was iso-
lated as described (25) and subsequently modified by deletion of
the 5
 
9
 
 untranslated region to position 143 to increase translational
efficiency. To generate a kinase-inactive mutant, a 21-mer oligo-
nucleotide primer, 5
 
9
 
-CTT CAG CGT CCT CAC TGC CAA-
3
 
9
 
, was used to convert Lys 279 (AAG) to Arg 279 (AGG). All
mutations in
 
 c-fgr
 
 cDNA were confirmed by DNA sequencing
(Sequenase; U.S. Biochemical). 
 
c-fgr
 
 constructs were cloned into
the retrovial vector pLNCX (Clontech), and pCLNX-
 
fgr
 
 cDNAs
or a vector control were transfected into the murine packaging
cell line, Psi-2 (American Type Culture Collection), as described
(26). After selection in 250 
 
m
 
g/ml G418, subclones were
screened for viral titer, clonal integration, and Fgr expression by
immunoblotting. 1 ml of helper-free virus at 10
 
5
 
–10
 
6
 
 PFU/ml
was used to infect 10
 
6
 
 BAC1.2F5 cells in the presence of 4 
 
m
 
g/ml
polybrene (Sigma Chemical Co.). After infection, clones were se-
lected in 250 
 
m
 
g/ml of G418. The following clones were used in
this investigation: vector control, BAC1.2F5 cells expressing a
vector control; Fgr(WT), BAC1.2F5 cells expressing various lev-
els of wild-type
 
 c-fgr
 
 of the p59 isoform; and Fgr(K279R),
BAC1.2F5 cells expressing 
 
c-fgr
 
 of the p59 isoform with a K279
to R279 mutation that inactivates kinase function. Expression of
Fgr protein was confirmed by Western blot analysis (see below
for details). Lack of Fgr kinase activity in Fgr(K279R)-expressing
cells was confirmed by an in vitro kinase assay based on auto-
phosphorylation of Fgr immunoprecipitates. In brief, Fgr protein
was immunoprecipitated with a polyclonal anti-Fgr peptide anti-
body (described below). The washed immunoprecipitates were
incubated with [
 
g
 
-
 
32
 
P]ATP for 30 min at 30
 
8
 
C, the kinase reac-
tion was terminated, and the eluted proteins were run on SDS-
PAGE. Fgr(WT) cells expressed 
 
32
 
P-labeled Fgr, whereas the
Fgr(K279R) cells did not (data not shown).
To confirm that cell surface expression of phagocytic receptors
was equivalent for all BAC1.2F5 clones, the cells were checked
by fluorescent flow cytometry with a FACScan
 
®
 
 cytometer (Bec-
ton Dickinson). Fc
 
g
 
RI was assessed by direct binding of FITC-
 
1
 
Abbreviations used in this paper:
 
 AI, attachment index; CSF-1, colony stim-
ulating factor 1; ECL, enhanced chemiluminescence; EC3bi, EIgG2a,
EIgG2b, and EIgGr, C3bi-, IgG2a-, IgG2b-, and rabbit IgG–opsonized
erythrocyte(s); HRP, horseradish peroxidase; HSA, human serum albu-
min; IAP, integrin-associated protein; ITIM, immunoreceptor tyrosine-
based inhibition motif; LCM, L cell–conditioned medium; MCF, mean
channel of fluorescence; PDBu, phorbol dibutyrate; PECAM-1, platelet-
endothelial cell adhesion molecule 1; PI, phagocytic index; PI 3-kinase, phos-
phatidylinositol 3-kinase; PIR-B, paired Ig-like receptor B; SH, Src ho-
mology; SHP, SH2 domain–containing protein tyrosine phosphatase; SIRP
 
a
 
,
signal regulatory protein of the 
 
a
 
 subtype; VBS, veronal-buffered saline.
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labeled purified monomeric murine IgG2a mAb S-S.1. Binding of
FITC-IgG2a was not blocked by mAb 2.4G2. Fc
 
g
 
RII/Fc
 
g
 
RIII
and CD11b were detected by indirect immunofluorescence using
biotinylated rat mAb 2.4G2 and M1/70, respectively, and FITC-
avidin. BAC1.2F5 clones (10
 
6
 
) were incubated with 1 
 
m
 
g of
antibody for 90 min at 0
 
8
 
C, washed, incubated with 0.1 
 
m
 
g of
FITC-avidin where appropriate, washed, and fixed in 1% paraform-
aldehyde in PBS. Levels of expression for these phagocytic recep-
tors were equivalent for all BAC1 clones. These cells were main-
tained in DMEM containing 15% FCS, 15–25% conditioned
media from L929 cells as a source of CSF-1, 100 U/ml penicillin,
100 
 
m
 
g/ml streptomycin, 4,500 mg/l glutamine, and 200 
 
m
 
g/ml
G418. Tissue culture reagents were purchased from GIBCO
BRL. All cell lines were routinely checked for 
 
Mycoplasma
 
 con-
tamination by PCR (Boehringer Mannheim).
 
Isolation of Primary Phagocytes.
 
Bone marrow macrophages,
resident peritoneal macrophages, and bone marrow neutrophils
(PMNs) were isolated from wild-type C57BL/6 mice, from
Fgr
 
2
 
/
 
2
 
 mice in the C57BL/6 background (22), from 
 
motheaten vi-
able
 
 (
 
me
 
v
 
/me
 
v
 
) mice obtained from The Jackson Laboratory, and
FcR knockout mice (
 
g
 
 chain knockout crossed with an FcRIIB
knockout) in C57BL/6 
 
3
 
 129 mice obtained from Taconic
Farms. Mice heterozygous for the targeted deletion of 
 
fgr
 
 were
bred, and the homozygous null offspring were detected by PCR
of tail vein DNA as described (22). All mice were housed under
sterile pathogen-free conditions. Phagocytes isolated from ho-
mozygous null mice generated by targeting either exon 2 or 4
gave equivalent results. Resident peritoneal macrophages were
obtained by lavage of the peritoneum with 5 ml buffer and were
plated onto fibronectin-coated Lab-Tek chambers. Bone marrow
leukocytes were flushed from the femurs. Bone marrow PMNs
were isolated by NIM-2 isolation media (Cardinal Associates) as
described (27). Bone marrow macrophages were cultured as de-
scribed (28) with the following modifications: the nonadherent
precursor cells were cultured in tissue culture flasks, instead of
bacteriologic petri dishes, in the presence of 15% L cell–condi-
tioned medium (LCM) for 3–5 d. The level of Fgr was signifi-
cantly reduced in cells cultured for 
 
.
 
5 d and in lower concentra-
tions of LCM (2–5%).
Adherent BAC1.2F5 cells and bone marrow macrophages
were released from tissue culture flasks by incubation with 5 mM
EDTA in PBS for 15 min at 37
 
8
 
C. All phagocytes were washed
twice in buffer and resuspended in HBSS containing 10 mM
Hepes, 0.5 mM Ca
 
2
 
1
 
, 2.5 mM Mg
 
2
 
1
 
, 50 
 
m
 
g/ml gentamicin, and
1% sterile, endotoxin-free human serum albumin (HBSS with 1%
HSA) at 2 
 
3 
 
10
 
6
 
/ml. For some experiments, analyses were per-
formed in complete tissue culture medium containing 15% LCM
with qualitatively similar results. Reactions with cells in suspen-
sion were performed in 12 
 
3
 
 75 mm polypropylene tubes (Falcon
Labware), and reactions with adherent cells were performed on ei-
ther polystyrene 24-well plates (Falcon Labware) or on 8-chamber
Lab-Tek glass slides (Nunc). To facilitate equivalent cell adhesion
for all of the transfected cells, adherent assays were performed on
plates or slides that had been coated overnight at 4
 
8
 
C with 2 
 
m
 
g/
ml murine fibronectin in PBS.
 
Opsonization.
 
Erythrocytes (BioWhittaker) were opsonized
with polyclonal rabbit anti–sheep erythrocyte (EIgGR) as described
previously (5, 6). For EIgG2a and EIgG2b (27), erythrocytes
were washed in veronal-buffered saline (VBS), and 200 
 
m
 
l (10
 
9
 
/ml)
was incubated with the indicated volume of the respective hybrid-
oma tissue culture supernatant or purified antibody for 30 min at
37
 
8
 
C. For EC3bi, erythrocytes were washed and suspended in
dextrose-buffered VBS containing 170 mM dextrose, 0.15 mM
CaCl
 
2
 
, and 1.0 mM MgCl
 
2
 
 (at 10
 
9
 
/ml) and incubated with an
equal volume of a subagglutinating dilution of rabbit IgM anti-
erythrocyte (6) for 30 min at 37
 
8
 
C. 200 
 
m
 
l of EIgM was incu-
bated with an equivalent volume of either a 1:5 or 1:10 dilution
of C5-deficient mouse serum (Jackson ImmunoResearch Labs)
for 60 min at 37
 
8
 
C. Opsonized erythrocytes were then washed
and resuspended in the respective buffer at 5 
 
3 
 
10
 
8
 
/ml.
 
Attachment and Phagocytosis Assays.
 
To assess binding of the
opsonized erythrocytes, washed macrophages (2 
 
3
 
 10
 
5
 
/ml) were
centrifuged at 100 
 
g
 
 with either 7.5 
 
m
 
l of EIgG2a or EIgG2b, or
25 
 
m
 
l of EC3bi in 100 
 
m
 
l of buffer for 1 min to initiate contact.
The reaction mixtures were incubated at 4
 
8
 
C for 30 min for
EIgG2a and EIgG2b, and at 37
 
8
 
C for 1 h for EC3bi. Attachment
was assessed by light microscopy, and the attachment index (AI)
was quantitated as the number of erythrocytes bound per 100
macrophages. Additionally, attachment of EIgG2a and EIgG2b at
37
 
8
 
C to macrophages that had been preincubated with 10 
 
m
 
M
cytochalasin B (Sigma Chemical Co.) to inhibit internalization
gave equivalent results. For optimal EC3bi attachment, most ex-
periments were performed in the presence of 1.0 mM Mn
 
2
 
1
 
. To
prove that EC3bi attachment was mediated by CR3, macrophages
were incubated with 1 
 
m
 
g of mAb 2E6 hamster anti–murine 
 
b
 
2
 
for 30 min at 0
 
8
 
C before the addition of EC3bi. mAb 2E6
blocked all EC3bi attachment.
Phagocytosis was assessed with macrophages either in suspension
or adherent to fibronectin-coated plates. For the suspension assay,
washed macrophages (2 
 
3
 
 10
 
5
 
) were centrifuged with 7.5 
 
ml of
EIgG2a, EIgG2b, or EIgGR, or 25 ml of EC3bi at 100 g for 1 min.
The mixtures were gently resuspended in 100 ml buffer. For
EC3bi, 30 ng/ml of phorbol dibutyrate (PDBu) and 1 mM MnCl2
were added to stimulate ingestion. PMN phagocytosis of EIgG2b
was assessed in the presence of buffer or various concentrations of
FMLP as described (27). After incubation for 30 min at 378C,
uningested erythrocytes were removed by hypotonic lysis. Phago-
cytosis was assessed by phase microscopy and quantitated as a
phagocytic index (PI), the number of opsonized erythrocytes in-
gested per 100 macrophages. Additionally, the percentage of
phagocytosis was tabulated by counting the number of cells in-
gesting at least 1 opsonized erythrocyte per 100 macrophages.
Phagocytosis was also assessed using adherent cells. Washed mac-
rophages (105/ml) were added to fibronectin-coated 24-well
plates. After incubation at 378C for 2 h, the cells were washed
and 100 ml of EIgGR was added. After 30 min at 48C, the non-
adherent EIgGR were washed away and ingestion was initiated
by incubation at 378C for 30 min. Uningested erythrocytes were
removed by hypotonic lysis. The cells were fixed with 2.5% glu-
taraldehyde in PBS for 10 min at room temperature. Phagocytosis
was assessed by photomicroscopy.
Macropinocytosis Assay. Macropinocytosis was defined by the
uptake of FITC-labeled 70-kD dextran as described by Araki et al.
(29). Vector control and Fgr(WT)-expressing BAC1.2F5 cells
were cultured for 16 h in the absence of LCM to remove the in-
fluence of CSF-1. Washed cells were resuspended at 107/ml in
HBSS with 1% HSA. A 100-ml aliquot of this suspension was
pulsed with FITC-labeled 70-kD dextran (5 mg/ml) for 1 h at
378C in the absence or presence of 6 ng of murine recombinant
CSF-1 (R & D Systems), washed three times, and chased for 1 h
at 378C in HBSS without HSA. In some experiments, the mac-
rophages were preincubated with 10 nM wortmannin to inhibit
phosphatidylinositol 3-kinase (PI 3-kinase) before incubation
with FITC-dextran (29). The cells were washed three times at
48C and placed on ice until fluorescence was assessed by flow cy-
tometry. Autofluorescence of cells that were not incubated with
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the FITC-dextran was subtracted to obtain specific fluorescence.
The data are reported as the mean channel of fluorescence
(MCF). The mean channel for autofluorescence was ,2 for all
experiments.
Receptor-mediated Endocytosis. Receptor-mediated endocytosis
of FcgRII/FcgRIII was assessed by an adaptation of the method
of Lamaze et al. (30). Receptor cross-linking and internalization
were initiated by incubating 1.0 3 106 vector control and
Fgr(WT)-expressing BAC1.2F5 cells at 08C with 1 mg of rat mAb
2.4G2 in 50 ml of serum-free culture medium containing 20 mM
Hepes and 0.2% BSA. After 1 h, the cells were washed and incu-
bated with 1 mg biotinylated F(ab)92 goat anti–rat IgG. After
washing, separate aliquots of the cells were incubated either at
08C to measure the total amount of cross-linked receptors or at
378C to initiate receptor internalization. After the indicated times
(15 min, 30 min, or 1 h), all of the samples were washed and in-
cubated with 0.1 mg FITC-avidin at 08C to measure surface fluo-
rescence. The samples were held at 08C until examined by flow
cytometry. The loss of surface staining on the 378C-incubated
samples was attributed to the internalization of the cross-linked
receptors. The percentage of endocytosis was calculated by the
following equation: % endocytosis 5 [(FL1 at 08C autofluores-
cence) 2 (FL1 at 378C autofluorescence)/(FL1 at 08C autofluo-
rescence)] 3 100. The data are represented as the mean 6 SEM,
n 5 3.
Detection of F-actin Distribution by Fluorescence Microscopy. The
extent of F-actin content in phagocytic cups surrounding the op-
sonized E was measured by the method of Greenberg et al. (31,
32). Vector control and Fgr(WT) BAC1.2F5 cells adherent for
glass coverslips were incubated with EIgGR in HBSS with 1%
HSA at 48C. After 1 h, the cells were washed three times and
warmed buffer was added to initiate ingestion. After 8 min at
378C, the cells were fixed with 1% paraformaldehyde in PBS for
30 min at 378C. After washing, the cells were permeabilized with
1% Triton X-100 in PBS for 30 min at room temperature,
washed, and incubated with a 1:50 dilution of rhodamine-phal-
loidin for 2 h at 48C. Slides were mounted with Fluoromount G
(Southern Biotechnology) and examined by fluorescence photo-
microscopy. The extent of actin cup formation by macrophages
that had bound at least 4 EIgGR was assessed by quantitating the
number of actin cups formed by 100 rosetted macrophages and
the percentage of cells that had at least 1 actin cup. No actin cups
were detected at 5 min after the initiation of phagocytosis.
Immunoprecipitations and Western Blotting. To assess expression
of Fgr by Western blotting, a rabbit polyclonal antibody to a pep-
tide corresponding to an NH2-terminal sequence Phe 23–Ser 43
of murine Fgr was generated. The Ser 43 residue in the synthetic
peptide was replaced by Cys to facilitate coupling of the protein
to KLH. Rabbits were immunized with 200 mg peptide-coupled
KLH in complete Freund’s adjuvant. Affinity-purified antibodies
were prepared from high titer sera on immobilized peptide col-
umns (Sulfolink Coupling Gel; Pierce Chemical Co.). The affin-
ity-purified antibody does not react with either murine Hck or
murine Lyn. Washed and resuspended macrophages were lysed in
1% NP-40, 50 mM Tris-HCl, pH 7.5, containing 150 mM
NaCl, 5 mM EDTA, 50 mM NaF, 10 mM Na pyrophosphate,
2 mM Na3VO4, 1 mM PMSF, and 2 mg/ml aprotinin (lysis
buffer). Cell lysates standardized for protein content (Bio-Rad
Labs) were precleared with rabbit IgG bound to protein-Sepharose
4B (Amersham Pharmacia Biotech) before SDS-PAGE on 10%
acrylamide gels. After electrophoresis, proteins were transferred
to Immobilon-P membranes (Millipore Corp.) and probed with
the affinity-purified anti–NH2-terminal peptide at 2 mg/ml in
10% nonfat milk in PBS. Rabbit antibody was detected by 0.05
mg/ml horseradish peroxidase (HRP)-conjugated goat polyclonal
anti–rabbit IgG (Vector Labs), and the membrane was developed
with enhanced chemiluminescence (ECL; Pierce Chemical Co.)
and exposed to BioMax MR film (Eastman Kodak Co.).
For immunoprecipitation of SIRPa after FcgR cross-linking,
vector control and Fgr(K279R) kinase-inactive BAC1.2F5 cells
were cultured in the absence of LCM for 24 h. The cells were
detached, washed, and resuspended in HBSS with 1.0 mM CaCl2
and 1.0 mM MgCl2. To aggregate FcgRs, 6 3 106 cells were in-
cubated with 25 mg/ml of rat mAb 2.4G2 at 48C for 30 min.
Equivalent data were obtained when IgG-opsonized ghosts were
used to aggregate FcgRs. After washing, the cells were resus-
pended to 50 ml and incubated with 25 mg/ml of goat IgG anti–
rat IgG (Sigma Chemical Co.) at 378C for 0 s, 30 s, 2 min, and 5
min. The cells were pelleted and lysed with 1% Triton X-100 in
lysis buffer for 15 min at 08C. The lysates were clarified by cen-
trifugation, normalized for protein levels, and precleared by incu-
bation with protein G–agarose for 1 h. SIRPa was immunopre-
cipitated by addition of purified rat IgG1 mAb P84 (23) bound to
protein G overnight at 48C. Beads were washed with lysis buffer
containing 1 mM Na3VO4 and 1 mM PMSF and eluted by boil-
ing 5 min in 23 Laemmli SDS buffer. The samples were run on
SDS-PAGE, and the resolved proteins were transferred to polyvi-
nylidene difluoride membrane. The membranes were blocked
with 2% BSA, 25 mM Tris-HCl, pH 7.5, 137 mM NaCl, 0.1%
Tween 20, and then probed individually with the following anti-
bodies: 0.125 mg/ml anti-PY RC20-HRP (Transduction Labs),
2 mg/ml rabbit anti-Fgr NH2 peptide, 1 mg/ml rabbit IgG anti–
SHP-1 (Upstate Biotechnology), or 1 mg/ml of rabbit IgG anti-
SIRPa (Alexis). The RC20-HRP–probed membranes were de-
veloped directly by ECL, whereas the rabbit antibody–probed
membranes were incubated with HRP-conjugated goat anti–rab-
bit IgG before ECL and exposure to film. Controls included cell
lysates incubated with protein G–Sepharose alone and immuno-
precipitation with a rat mAb against murine CD29.
Tyrosine Phosphatase Activity Associated with SIRPa. To assess
functional tyrosine phosphatase activity associated with SIRPa
after FcR activation, we incubated SIRPa immunoprecipi-
tated from vector control and Fgr(K279R)-expressing BAC1.2F5
cells as described above with a phosphotyrosine peptide
(RRLIEDAEpYAARG) overnight at 378C. Liberated phosphate
was detected by malachite green using a Tyrosine Phosphatase
Assay Kit 1 (Upstate Biotechnology), following the manufac-
turer’s instructions. Liberated phosphate was measured in pico-
moles from a standard curve. To assess specific phosphatase activ-
ity, the phosphate levels detected with protein G–agarose beads
incubated with cell lysates in the absence of anti-P84 were sub-
tracted from the levels detected with anti-P84. This amount was
,10% of the total phosphate detected. The data are representa-
tive of two experiments, each performed in duplicate.
Results
Fgr Negatively Regulates Phagocytosis Mediated by Multiple
Ligand–Receptor Pairings Both in a Macrophage Cell Line and
in Primary Macrophages. To test our hypothesis that Fgr
mediates negative regulation of phagocytosis, we used
BAC1.2F5 cells, which exhibit many of the functions of
mature macrophages (24), and which we had determined
in preliminary experiments did not express Fgr protein.
The cells were retrovirally infected with either a vector
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control or wild-type murine c-fgr and assessed for the ability
to bind and ingest EIgG2a, EIgG2b, and EC3bi. Both the
vector control and Fgr(WT)-expressing cells had compara-
ble levels of Src, Hck, Lyn, and Syk and expressed equiva-
lent amounts of cell surface receptors, including FcgRI,
FcgRII/FcgRIII, and CR3 (data not shown). Ingestion of
both EIgG2a and EIgG2b was significantly suppressed in
Fgr(WT)-expressing cells at all levels of opsonization (Fig.
1, A, C, and D). Moreover, ingestion was suppressed for
both the total number of opsonized targets ingested (Fig. 1,
A and C) and the percentage of cells ingesting (Fig. 1, B
and D). However, FcR-mediated phagocytosis in the
Fgr(WT)-expressing cells did increase with increasing con-
centrations of opsonin (Fig. 1, A and C), indicating that the
cells were capable of mounting a phagocytic response, but
that it was attenuated relative to the vector control cells. At
levels of opsonization where 80–90% of the vector control
cells ingested, only 40–45% of the Fgr(WT) cells were ca-
pable of internalizing the bound targets (Fig. 1, B and D).
The same results were obtained with BAC1.2F5 cells ad-
herent on fibronectin-coated plates and ingesting rabbit
IgG–opsonized erythrocytes (data not shown). These data
indicate that Fgr suppresses phagocytosis by FcgRs on mu-
rine macrophages and that the suppression cannot be over-
come by increasing the concentration of ligand.
Because signal transduction pathways could vary for phago-
cytosis mediated by different classes of receptors (2, 3, 6,
33–35), the ability of Fgr to suppress ingestion could be
limited to a single class of receptor, i.e., Fcg. Therefore, we
assessed the effect of Fgr expression on CR3 (CD11b/
CD18)–mediated ingestion of EC3bi. Unlike FcgRs, CR3
is not constitutively able to ingest C3bi-opsonized targets,
and additional stimuli, like phorbol esters, are required for
efficient internalization (2, 4, 6, 33). Even in the presence
of 30 ng/ml of PDBu, Fgr(WT)-expressing macrophages
ingested significantly fewer EC3bi than did vector control
cells (Fig. 1 E). In addition, the percentage of cells ingesting
EC3bi was suppressed in Fgr(WT) cells (Fig. 1 F). Increas-
ing the concentration of PDBu could not overcome the
suppression of ingestion (data not shown). No phagocytosis
of EC3bi was observed with either cell type in the absence
of PDBu (data not shown). These data indicate that Fgr is
able to suppress phagocytosis mediated by multiple phago-
cytic receptors.
One trivial explanation for our results could be that ex-
pression of Fgr alters the optimal attachment of the op-
sonized target to the phagocyte. Therefore, we quantitated
attachment for EIgG2a, EIgG2b, and EC3bi to vector con-
trol and Fgr(WT)-expressing cells to rule out this possibil-
ity. Equivalent AIs were obtained for EIgG2a (AI 5 386 6
25 and 389 6 16, n 5 3, for vector control and Fgr[WT],
respectively) and EIgG2b (AI 5 426 6 20.4 and 422 6 18,
n 5 3, for vector control and Fgr[WT], respectively)
whether attachment was assessed at 48C or 378C with cyto-
chalasin B–treated macrophages. In addition, AIs for EC3bi
binding at 378C in the absence of PDBu but in the pres-
ence of Mn21 were equivalent for the two cell types (AI 5
140 6 9 and 154 6 9, n 5 3, for vector control and
Fgr[WT], respectively). These data indicate that Fgr sup-
presses FcgR- and CR3-mediated ingestion, but not ligand
binding. Taken together, all of the above data suggest that
Fgr suppresses ingestion mediated by multiple receptors at a
point subsequent to receptor ligation.
Because overexpression of Fgr could be artificially sup-
Figure 1. (A–D) Effect of increasing con-
centrations of opsonin, IgG2a (A and B) and
IgG2b (C and D), on FcR-mediated phago-
cytosis by vector control (black bars) and
Fgr(WT)-expressing (hatched bars) macro-
phages. Macrophages (2 3 105) and the ap-
propriately opsonized erythrocytes were in-
cubated in suspension in 100 ml of culture
medium. After 30 min at 378C, uningested
erythrocytes were lysed, and phagocytosis
was assessed by light microscopy. PI, the
number of opsonized erythrocytes ingested
by 100 phagocytes (A and C). % Phagocy-
tosis, the number of cells ingesting per 100
phagocytes (B and D). The data are de-
picted as the mean 6 SEM, n 5 3. These
data indicate that increasing the concentra-
tion of opsonin, either IgG2a or IgG2b,
cannot overcome the suppression of phago-
cytosis mediated by Fgr. (E and F) Effect of
Fgr(WT) (hatched bars) expression com-
pared with a vector control (black bars) on
ingestion of EC3bi by macrophages (E and
F). Macrophages (2 3 105) and 25 ml of
EC3bi were incubated with 30 ng/ml of
PDBu in 100 ml of HBSS containing 1%
HSA and 1 mM MnCl2 to stimulate ingestion. After 30 min at 378C, the uningested erythrocytes were lysed, and the PI (E) and percentage of phagocy-
tosis (F) were assessed by light microscopy. The data are depicted as the mean 6 SEM, n 5 3. These data indicate that Fgr suppresses CR3-mediated in-
gestion in addition to FcgR-mediated ingestion.
520 Fgr Tyrosine Kinase and Negative Regulation of Phagocytosis
pressing phagocytosis, we assessed ingestion in Fgr(WT)
BAC1.2F5 cells expressing varying levels of Fgr protein
and in primary phagocytes from wild-type and mice defi-
cient in Fgr expression by targeted gene deletion (22).
Three Fgr(WT)-infected clones that expressed from 11 to 41
Fgr protein compared with the Fgr-negative vector control
(Fig. 2 A) were assessed for their ability to ingest EIgG2a,
EIgG2b, and EC3bi. As shown in Fig. 2 B, increasing con-
centrations of Fgr protein resulted in significantly decreased
phagocytic responses for all three types of opsonized eryth-
rocytes. Moreover, resident peritoneal macrophages and
bone marrow macrophages from Fgr2/2 mice ingested sig-
nificantly greater numbers of EIgG2a and EC3bi compared
with macrophages from wild-type mice (Fig. 3, A and B).
However, ingestion of EIgG2b was not as dramatically af-
fected by Fgr expression as it was in the BAC1.2F5 cells
(Fig. 3 B). The greatest difference was observed in resident
peritoneal macrophages that expressed much higher levels
of Fgr protein than did cultured bone marrow macrophages
(data not shown). We also observed that the time, method,
and concentration of LCM used for culture of the bone
marrow macrophages affected Fgr expression, consistent with
previous work (25). In contrast to macrophages, PMNs
from Fgr2/2 mice ingested significantly fewer EIgG2b even
with FMLP stimulation to obtain optimal levels of inges-
tion (27). The fact that Fgr is essential for optimal FcR-
mediated phagocytosis in PMNs had not been observed
previously (22) and suggests that the role of Fgr in regulat-
ing PMN phagocytic responses is more complex. The data
depicted in Figs. 2 and 3 indicate that expression of Fgr either
in a macrophage cell line or in primary macrophages nega-
tively regulates the magnitude of the phagocytic response.
Fgr Does Not Affect Macropinocytosis, Another Membrane
Fusion Event That Requires PI 3-Kinase. To assess whether
Fgr expression affects other functions of macrophages that
have signaling elements in common with phagocytosis, we
examined the effect of Fgr expression on macropinocytosis,
another mechanism by which uptake of particles as large
as bacteria can occur (36, 37). Formation of macropino-
somes requires PI 3-kinase and actin polymerization (29,
36), two signaling elements required by both FcgR- and
CR3-mediated ingestion (29, 31, 33). We assessed macro-
pinocytosis by the uptake of FITC-labeled 70-kD dextran
(29) into macropinosomes measured both by fluorescence
microscopy and flow cytometry to quantitate the amount
of cell-associated fluorescence. Vector control and Fgr(WT)-
expressing BAC1.2F5 cells took up the labeled dextran
equivalently, and large macropinosomes were visualized in
both cell types (data not shown). In addition, the level of
cell-associated fluorescence was quantitatively identical as
assessed by flow cytometry (MCF 5 120 6 19 vs. 104 6 16,
n 5 3, for the vector control and Fgr[WT] cells, respec-
tively). Moreover, inclusion of CSF-1 to stimulate macro-
pinocytosis (29) increased the cell-associated fluorescence
equivalently in both cell lines (MCF 5 233 6 53 vs. 216 6
41; data not shown). To prove that the mechanism of up-
take was similar in both the absence and presence of Fgr,
we assessed the effect of 10 nM wortmannin, a PI 3-kinase
inhibitor, on macropinocytic uptake. The histograms of
both the vector control and the Fgr(WT)-expressing cells
were shifted significantly to the left by the inclusion of
wortmannin, indicating an essential role for PI 3-kinase in
macropinocytic uptake by both cell lines (data not shown).
These data indicate that not all mechanisms for uptake by
macrophages are negatively affected by Fgr expression.
Fgr Negatively Regulates FcgR-mediated Ingestion at a Point
Distal to Receptor Clustering and Aggregation, but Proximal to
the Reorganization of F-actin into Phagocytic Cups. To delin-
eate the point in phagocytosis where Fgr exerts its effect,
we examined both an early (receptor cross-linking) and a
later (phagocytic cup formation) process that are essential
for FcgR-mediated ingestion. Opsonin-dependent phago-
cytosis is initiated by engagement of specific receptors with
ligands on the target surface, which induces receptor aggre-
gation and migration into membrane domains where cyto-
plasmic signaling molecules are activated (1–3, 37). In fact,
cross-linking of FcgRII/FcgRIII with a rat mAb against
these receptors and a polyclonal anti–rat antibody is suffi-
cient to activate downstream signaling molecules that are
essential for phagocytosis mediated by these receptors and
to mediate receptor internalization via endocytic mecha-
Figure 2. (A) Variable Fgr expression in three different BAC1.2F5
clones as assessed by Western blotting. (B) Effect of variable levels of
Fgr(WT) expression (graded 11 to 41 by Western blotting, hatched and
dotted bars) compared with a vector control (black bars) on ingestion of
EIgG2a, EIgG2b, and EC3bi by BAC1.2F5 macrophages. The data are
depicted as the mean 6 SEM, n 5 3. These data indicate that Fgr sup-
presses phagocytosis in a dose-dependent manner.
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nisms (1, 34–38). As an example, the small GTPase, Rho,
is required for phagocytosis, and the earliest step it regulates
is Fcg receptor clustering (38). Because the primary intra-
cellular location for Src family kinases is the plasma mem-
brane (39), Fgr could interfere with phagocytosis by block-
ing receptor aggregation and subsequent endocytosis. To
examine this, we assessed the effect of Fgr expression on
the endocytosis of FcgRII/FcgRIII induced by antibody-
mediated aggregation as a measure of receptor clustering
and aggregation. The percentage of internalized FcgRII/
FcgRIII was equivalent for both vector control and
Fgr(WT)-expressing cells at all three time points examined
up to 1 h (from 36.2 6 4.6% at 15 min to 69 6 1.6% at 1 h
for the vector control cells, compared with 34.4 6 9.2% at
15 min and 62 6 5.2% at 1 h for the Fgr[WT] cells; n 5 3).
Because FcgR clustering and aggregation is required for
endocytosis and endocytosis is not affected by Fgr expres-
sion, these data indicate that this early event is not affected
by Fgr expression. Because this early event was not in-
volved, we wanted to determine if the kinetics of ingestion
was affected by Fgr expression or whether it simply blocked
ingestion after a certain number of targets were internal-
ized. As shown in Fig. 4, Fgr expression suppressed inter-
nalization as early as 10 min, suggesting that it was attenu-
ating the phagocytic response throughout the time course
of the assay. These data indicate that Fgr suppresses inges-
tion at some point distal to FcgR clustering and activation
and that this suppression occurs early in the internalization
process.
After FcgR cross-linking and initiation of intracellular sig-
naling, within 5–10 min, pseudopodia containing F-actin
extend over the surface of the target and create actin-rich
phagocytic cups (1, 31–33). To assess the effect of Fgr
on actin cup formation, adherent vector control and Fgr
(WT)-expressing cells were allowed to attach EIgGR at
48C for 2 h. After washing away the unbound EIgGR,
phagocytosis was initiated by incubation at 378C for 8 min.
The distribution of F-actin relative to the bound EIgGR
was visualized by rhodamine-phalloidin staining and fluo-
rescence microscopy. At this time point, before a signifi-
cant level of ingestion had occurred (Fig. 4), a majority of
the vector control cells had F-actin distributed along the
surface of the attached target-forming fluorescent phago-
cytic cups that extended from the surface of the cells (Fig.
5, A and B, arrows). In contrast, very few of the Fgr(WT)-
expressing cells had demonstrable phagocytic cups even
though they had bound equivalent numbers of the op-
sonized targets (Fig. 5, C and D, arrows). In addition, the
F-actin subjacent to the attached targets did not extend as
far from the surface of the cell, suggesting a blunting of
pseudopod extension. To quantitate these data, we assessed
the number of actin cups formed per 100 cells that had at-
tached 4 or more EIgGR as well as the percentage of roset-
ting cells that had formed at least 1 actin cup. As shown in
Fig. 5 E, Fgr(WT) macrophages had significantly fewer ac-
tin cups formed per 100 cells, and only 30% of these cells
Figure 3. Comparison of phagocytic ability
of resident peritoneal macrophages (A), cul-
tured bone marrow macrophages (B), and bone
marrow neutrophils (C) from Fgr1/1 (Wild-
type, black bars) and Fgr2/2 mice (hatched
bars). Mice heterozygous for deletion of c-fgr
were bred, and homozygous null and positive
offspring were detected by PCR. Resident
peritoneal macrophages were obtained by la-
vage, bone marrow macrophages were cultured
for 5 d in LCM, and bone marrow neutrophils
were isolated by density gradient centrifugation.
PI, the number of opsonized erythrocytes in-
gested by 100 phagocytes. The data are de-
picted as the mean 6 SEM, n 5 3–4. These
data indicate that macrophages, but not neutro-
phils, from Fgr2/2 mice have enhanced phago-
cytic function.
Figure 4. Effect of Fgr expression on the kinetics of ingestion of
EIgGR. Vector control (s) and Fgr(WT)-expressing (d) BAC1.2F5
macrophages were allowed to attach EIgGR at 48C for 2 h. The reaction
was warmed to 378C, and ingestion was assessed at various times as de-
scribed in the legend to Fig. 1. These data indicate that Fgr expression
suppresses phagocytosis at every time point during the reaction.
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formed at least 1 actin cup, compared with 60–70% of the
vector control cells. The number of actin cups correlated
well with the PIs observed in the phagocytosis assays (Fig. 1).
We also assessed actin cup formation with EIgG2b and ob-
tained equivalent affects with Fgr expression (data not shown).
These data indicate that Fgr negatively regulates FcgR-medi-
ated phagocytosis at a point before the redistribution of F-actin
into phagocytic cups surrounding the attached targets.
Fgr That Lacks Tyrosine Kinase Function Is Sufficient to
Suppress Ingestion Mediated by Multiple Phagocytic Receptors.
The members of the Src tyrosine kinase family have a homol-
ogous domain structure, and the sequence of the COOH-ter-
minal kinase catalytic domain is highly conserved (39). Within
this domain, a critical lysine residue (K279 in murine Fgr) is
essential for ATP binding and phosphorylation of targeted ty-
rosine residues (40). Therefore, we assessed the effect of this
lysine residue on the suppression of phagocytosis mediated by
Fgr(WT). BAC1.2F5 cells expressing a mutant Fgr in which
the lysine at position 279 was changed to an arginine (K279R)
were compared with vector control and Fgr(WT)-expressing
cells for phagocytic responses. Surprisingly, Fgr(K279R) was
equally able to suppress ingestion mediated by both Fcg and
CR3 receptors, as was the wild-type form of murine Fgr (Fig.
6). Therefore, these data indicate that Fgr negatively regulates
phagocytosis by a mechanism that does not involve its ability
to phosphorylate any other protein.
Fgr Associates with a Complex of the ITIM-containing Recep-
tor SIRPa and the Phosphatase SHP-1 after FcgR Aggregation.
Positive signaling for FcgR-mediated phagocytosis involves
multiple kinases, including tyrosine, lipid, and serine-threo-
nine kinases (1–3). To address the signaling mechanism by
which Fgr could be suppressing phagocytosis, we began by
first assessing tyrosine phosphorylation patterns in vector
control and Fgr(K279R)-expressing cells after FcgR aggre-
gation. The use of the kinase-inactive cells (K279R), which
have suppressed phagocytic responses (Fig. 6), allowed us
to examine tyrosine phosphorylation independently of the
additional phosphorylation mediated by Fgr. In the vector
control cells, tyrosine phosphorylation of multiple proteins
was increased within 0.5–5 min after FcgR aggregation (Fig.
7 A). In contrast, tyrosine phosphorylation in the Fgr(K279R)
cells was significantly reduced, especially for proteins in the
95–120- and 50–65-kD range as soon as 30 s after FcR acti-
vation. Tyrosine-phosphorylated Fgr is prominent in the
56-kD range. This altered pattern of tyrosine phosphoryla-
tion after FcR aggregation in the Fgr(K279R) cells sug-
gested that the suppression of phagocytosis could be medi-
ated, at least in part, by the recruitment of a tyrosine
phosphatase to FcgR signaling domains.
Several inhibitory pathways involving phosphatase recruit-
ment can be triggered by the activation of ITIM-containing
receptors (41). In addition to the ITIM-containing FcgRIIB
Figure 5. Fluorescence microscopy of F-actin distri-
bution after the initiation of FcgR-mediated phagocy-
tosis by vector control (A and B) and Fgr(WT)-
expressing (C and D) macrophages. Macrophages
adherent to glass coverslips were incubated with
EIgGR at 48C. After washing away the unbound
EIgGR, the rosetted macrophages were incubated at
378C to initiate phagocytosis. After 8 min, the reaction
was stopped and the cells were fixed, permeabilized,
and incubated with rhodamine-phalloidin to stain po-
lymerized actin. The extent of actin cup formation was
assessed by fluorescence microscopy. The white arrows
indicate actin cups. These data indicate that the reorga-
nization of F-actin into cups surrounding the opsonized
erythrocytes is significantly inhibited by Fgr. (E) Effect
of Fgr(WT) (hatched bars) transfection compared with
a vector control (black bars) on the distribution of
F-actin into cups after the initiation of FcgR-mediated phagocytosis. The extent of actin cup formation by macrophages that had bound at least 4 EIgGR
was assessed by quantitating the number of actin cups formed by 100 rosetted macrophages (left) and the percentage of cells that formed at least 1 actin
cup (right). The data are represented as the mean 6 SEM, n 5 3. These data indicate that Fgr suppresses both the percentage and the total number of ac-
tin cups formed during FcgR-mediated phagocytosis.
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receptor, mouse macrophages express other members of
the inhibitory receptor family, including paired Ig-like re-
ceptor B (PIR-B), SIRPa, and platelet-endothelial cell ad-
hesion molecule 1 (PECAM-1) (42–44). Because Fgr sup-
presses ingestion of both IgG- and C3bi-opsonized targets
and because FcgRIIB is thought to inhibit only IgG-medi-
ated responses (12), we speculated that other ITIM-con-
taining receptors would be important for this negative reg-
ulation. Recently, both PIR-B and SIRPa were identified
as major substrates and binding partners for the phosphatase
SHP-1 in both BAC1.2F5 cells and bone marrow macro-
phages (42, 43). Because macrophages from mice with in-
activating mutations in SHP-1 (motheaten and motheaten via-
ble) are profoundly hyperresponsive, we hypothesized that
SHP-1 would be a major regulator of phagocytic responses
and that this regulation might be mediated through PIR-B
and/or SIRPa. Because preliminary investigations revealed
minimal expression of PIR-B relative to SIRPa on the vec-
tor control BAC1.2F5 cells, as suggested by others (43), we
assessed whether Fgr would coassociate with SIRPa after
FcgR aggregation and whether targeting SIRPa could af-
fect phagocytic responses. To immunoprecipitate SIRPa,
we used a rat mAb to an antigen first identified on neurons,
P84, and subsequently shown to be identical to SHP sub-
strate 1 (SHPS-1), BIT, and SIRPa (45). Vector control
and Fgr(K279R) cells were stimulated via FcgR aggrega-
tion for various times, and the cell lysates were immuno-
precipitated for SIRPa. The immunoprecipitates were sub-
jected to immunoblotting to assess SIRPa protein expression,
phosphorylated tyrosine content, Fgr association, and SHP-1
association. As shown in Fig. 7 B, the vector control and
Fgr(K279R) cells expressed equivalent levels of SIRPa that
was constitutively tyrosine phosphorylated. After FcgR ag-
gregation, the level of tyrosine phosphorylation declined,
and this reduction was much more pronounced in the Fgr-
negative cells. After 30 s, Fgr coassociated with SIRPa in
the Fgr(K279R) cells, and this association was pronounced
at 5 min. Minimal Fgr levels were detected in cell lysates in-
Figure 6. Effect of vector control (black bars), Fgr(WT) (hatched bars),
and kinase-inactive Fgr(K279R) (dotted bars) on phagocytosis of EIgG2a,
EIgG2b, and EC3bi. The experiments were performed as described in the
legend to Fig. 1. The data are representative of at least three experiments.
These data indicate that Fgr, which lacks tyrosine kinase activity, is suffi-
cient for suppression of phagocytosis mediated by multiple ligand–recep-
tor pairings.
Figure 7. (A) Effect of kinase-inactive Fgr expression on the tyrosine phosphorylation pattern in whole-cell lysates after FcgR aggregation. Vector
control and Fgr(K279R) BAC1.2F5 cells were incubated with rat mAb 2.4G2 anti-FcgRII/FcgRIII on ice for 1 h. After washing, the cells were incu-
bated with intact goat anti–rat at 378C for the indicated times. The cells were lysed and subjected to SDS-PAGE and Western blotting with anti-PY. Ex-
pression of kinase-inactive Fgr significantly suppressed tyrosine phosphorylation of several proteins as soon as 30 s after FcgR activation. (B) Coimmuno-
precipitation of Fgr and SHP-1 with SIRPa after aggregation of FcgRs. Vector control and Fgr(K279R)-expressing BAC1.2F5 cells were incubated
with rat mAb 2.4G2 on ice for 1 h. After washing, the cells were incubated with goat anti–rat at 378C for the indicated times. The cells were lysed, and
SIRPa was immunoprecipitated with rat mAb P84. After electrophoresis, the samples were subjected to Western blotting with either rabbit anti-SIRPa,
anti-PY, rabbit anti-Fgr, or rabbit anti–SHP-1. These data indicate that after FcgR activation, Fgr associates with the tyrosine-phosphorylated 130-kD
form of SIRPa and that this complex potentiates the association of SHP-1 with SIRPa. (C) Effect of Fgr expression on tyrosine phosphatase activity as-
sociated with SIRPa before and after FcgR aggregation. SIRPa immunoprecipitates from vector control and Fgr(K279R)-expressing BAC1.2F5 cells
both before (black bars) and after (hatched bars) FcgR aggregation (as in A and B) were assessed for tyrosine phosphatase activity by incubation with a
PY-containing peptide and measurement of liberated phosphate by malachite green absorption. The data are the mean of two experiments performed in
duplicate. These data indicate that after FcgR aggregation, two- to threefold more tyrosine phosphatase activity is associated with SIRPa in the Fgr-
expressing cells.
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cubated with protein G alone or immunoprecipitated with
rat anti-CD29 (data not shown). In addition, anti–PECAM-1
mAb did not coimmunoprecipitate with Fgr (data not
shown). As reported by others (42, 43), SHP-1 was consti-
tutively associated with SIRPa in both cells. However, in
the absence of Fgr, the level of coassociated SHP-1 de-
clined significantly after stimulation and was almost absent
at 5 min. In the presence of Fgr, there was an initial de-
crease in coassociated SHP-1 after FcgR stimulation, with
a subsequent increase at 2 and 5 min. These data suggest
that Fgr coassociates with SIRPa after FcgR aggregation,
and at the time of its maximal association (5 min), the ty-
rosine phosphorylation level of SIRPa is higher and there
is a greater amount of coassociated SHP-1 compared with
this time point in the absence of Fgr. To address whether
this correlated with functional tyrosine phosphatase activ-
ity, we assessed the ability of the SIRPa immunoprecipi-
tates to release phosphate from a pY-containing peptide.
As shown in Fig. 7 C, after FcgR aggregation and activa-
tion, more tyrosine phosphatase activity was associated
with SIRPa in the Fgr(K279R)-expressing compared with
the vector control BAC1.2F5 macrophages.
To obtain evidence that SIRPa and SHP-1 could be
implicated in regulating phagocytic responses, we assessed
the effect of the P84 mAb against SIRPa on phagocytosis
of EC3bi and EIgG2a by wild-type and Fgr2/2 bone mar-
row macrophages (Fig. 8 A) and by vector control and
Fgr(K279R)-expressing BAC1.2F5 cells (Fig. 8 B). Incuba-
tion of Fgr-expressing primary macrophages or BAC1.2F5
cells with mAb P84 anti-SIRPa significantly enhanced phago-
cytosis of both EC3bi and EIgG2a. An isotype control an-
tibody that recognizes an antigen expressed by both cell
types, CD14, had no effect. In contrast, incubation of Fgr2/2
macrophages with anti-SIRPa had no effect on their
phagocytic responses. Antibody against PECAM-1, an-
other ITIM-containing receptor on these cells, also had no
effect on ingestion by either cell type (data not shown). To
assess whether the absence of the ITIM-containing recep-
tor, FcgRIIB, could modulate this, we examined the effect
of mAb anti-P84 on ingestion of EC3bi by macrophages that
lack all three FcgRs, including FcgRIIB. Ingestion in the
presence of the isotype control mAb was equivalent for both
the wild-type and FcgR knockout macrophages (PI 5 80 6
4 vs. 76 6 2, n 5 3, respectively; data not shown). In addi-
tion, treatment with mAb P84 increased ingestion equiva-
lently for both cell types (PI 5 187 6 14 vs. 176 6 8, n 5 3,
respectively). These data indicate that the absence of the in-
hibitory FcgRIIB does not enhance phagocytosis of EC3bi
and that anti-SIRPa is able to enhance EC3bi ingestion
even in the absence of FcgRIIB. These data indicate that
mAb P84 anti-SIRPa can reverse the negative regulatory ef-
fect of Fgr on FcgR- and CR3-mediated phagocytosis in a
manner independent of the inhibitory FcgRIIB receptor.
To examine the role of SHP-1, we assessed ingestion of
EIgG2a, EIgG2b, and EC3bi by cultured bone marrow
macrophages from motheaten viable mice compared with
control mice. As shown in Fig. 8 C, ingestion of both
EIgG2a and EC3bi was markedly enhanced by mev/mev
macrophages. As with the Fgr2/2 macrophages (Fig. 4), in-
gestion of EIgG2b was not significantly augmented. To ex-
amine whether SIRPa modulates ingestion by mev/mev
macrophages, we assessed the effect of mAb P84 on the in-
gestion of EIgGR by these cells. While mAb P84 signifi-
cantly enhanced ingestion by wild-type macrophages (PI 5
80 6 7 control mAb vs. 247 6 40 mAb P84, n 5 3), it had
no effect on ingestion by the mev/mev macrophages (PI 5
267 6 35 control mAb vs. 270 6 34 mAb P84; data not
shown). Because PIs in these cells can be .400 (Fig. 8 C),
these data cannot be explained by a failure to enhance an
already optimal level of ingestion. These data indicate that
macrophages that contain a functionally inactive SHP-1
have enhanced phagocytic responses equivalent to those
observed in Fgr2/2 macrophages and that anti-SIRPa can-
not enhance their phagocytic responses any further.
Figure 8. Effect of mAb P84
anti-SIRPa on phagocytosis by
Fgr1/1 and Fgr2/2 bone marrow
cultured macrophages (A) and
vector control and Fgr(K279R)-
expressing BAC1.2F5 cells (B).
Cells were incubated with rat
IgG1 anti-CD14 or rat IgG1 P84
for 15 min at room temperature.
Ingestion of either EIgG2a or
EC3bi was assessed as described.
These data indicate that anti-P84
(dotted bars) enhances phagocyto-
sis by Fgr-expressing macrophages
compared with the isotype con-
trol (hatched bars). (C) Compari-
son of phagocytosis of EIgG2a,
EIgG2b, and EC3bi by bone mar-
row macrophages from wild-type
(black bars) and motheaten viable
[me(v)] mice (hatched bars).
These data indicate that mice with
a nonfunctional form of SHP-1
have enhanced phagocytic ability.
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Discussion
Phagocytes play an essential role in homeostasis by me-
diating the internalization and destruction of microbial
pathogens. Two distinct molecular mechanisms for patho-
gen uptake have been proposed: one is the “zipper” mech-
anism that depends on repeated receptor–ligand interac-
tions to drive pseudopod advance over the particle surface,
and the other is a “trigger” mechanism that depends on the
formation of membrane ruffles that fold back onto the sur-
face of the cell, creating macropinosomes containing extra-
cellular fluid and associated particles (37). Swanson and
Baer (37) have observed that the two mechanisms differ in
the magnitude of the pseudopodia produced relative to the
size of the particle: zippering produces a small pseudopod
and triggering a large one. These authors hypothesize that
this difference arises by spatially controlled production of
both excitatory and inhibitory signals in the ligand–recep-
tor driven model of zippering (37). We contend that limi-
tation or spatial control of the magnitude of the signal is
beneficial to the host. Because ligation of FcgRs can ini-
tiate signals that generate reactive oxidants and release of
lysosomal enzymes, spatial control would limit their pro-
duction to the forming phagolysosome. A prediction of this
hypothesis would be that negative signaling molecules could
be found in zippering but not triggering mechanisms. Our
present work indicates that the Src kinase family member,
Fgr, is a negative signaling molecule for the zippering
mechanism, phagocytosis, but not for the triggering mech-
anism, macropinocytosis. Moreover, the data presented in
our paper are consistent with a model of negative regula-
tion whereby Fgr raises the activation threshold necessary
to generate a given magnitude of response. In this model,
increasing the number of ligated and cross-linked receptors
on a particle of sufficient size to trigger a phagocytic re-
sponse (46) enhances the final readout of the pathway (i.e.,
ingestion) but cannot entirely overcome the negative sig-
naling component contributed by the inhibitor molecule.
These data demonstrate that Fgr, like the Src family ki-
nase member Lyn (17, 47, 48), plays an important role in
negative regulation of hematopoietic cell activation. Be-
cause Lyn negatively regulates activation of the B cell anti-
gen receptor and the high affinity receptor for IgE via
phorphorylation of ITIM-containing receptors that recruit
the lipid phosphatase SHIP (47, 48), we hypothesized that
Fgr might work by a similar mechanism. Although we have
obtained data implicating an ITIM-containing receptor ex-
pressed by macrophages, SIRPa, and a phosphatase, SHP-1
(Figs. 7 and 8), Fgr is clearly not responsible for phosphor-
ylation of the ITIM motif in SIRPa (Fig. 7 B), and a ki-
nase-inactive mutant is fully sufficient for the negative reg-
ulation of phagocytosis (Fig. 6). These data suggest that
another kinase must be responsible for phosphorylating
SIRPa and for regulating docking of SHP-1 in the plasma
membrane. Because Lyn actively phosphorylates ITIMs in
other receptors, it is intriguing to speculate that Lyn is re-
sponsible for phosphorylating SIRPa. If true, then the abil-
ity of Fgr to negatively regulate phagocytosis would be de-
pendent on the function of Lyn. In this paradigm, Fgr may
be functioning as an adaptor, through its SH2 and SH3 do-
mains, to facilitate the association of SHP-1 with tyrosine-
phosphorylated SIRPa (Fig. 9 B). Our data suggest a model
whereby Fgr, through its SH2 domain, could protect SIRPa
from dephosphorylation while allowing the recruitment
and docking of SHP-1. Although we have focused the cur-
rent studies on the regulation of tyrosine phosphorylation
by Fgr (Fig. 7), other signaling elements, such as lipid and
serine-threonine phosphatases, could also be involved. Fur-
ther study will be required to determine if all of Fgr’s abil-
ity to attenuate phagocytosis can be explained by recruit-
ment of SHP-1.
These data, along with those of Hunter et al. (49) and
Clynes et al. (12), which assessed the ability of inhibitory
FcgRIIB to negatively regulate ingestion by activating
FcgRs, are the first to define signal transduction elements
that negatively regulate phagocytosis. However, there are
some significant differences between our study and theirs.
In their studies, the IgG-opsonized particle binds both the
inhibitory receptor and the activating receptor, and the ob-
served inhibition is dependent on specific interactions in
the cytoplasmic regions of these two receptors (49). Thus,
human FcgRIIB suppresses ingestion mediated by human
FcgRIIA but not ingestion mediated by human FcgRIII
(49), whereas in our work Fgr suppressed ingestion by
multiple receptors including CR3, a non-IgG binding re-
ceptor. In fact, ingestion of EIgG2b, which is recognized
by both inhibitory FcgRIIB and activating FcgRIII in mu-
rine macrophages, was not enhanced significantly in the ab-
sence of Fgr (Fig. 4) or by the lack of functional SHP-1
(Fig. 8). Moreover, the absence of FcgRIIB did not enhance
ingestion of EC3bi, whereas anti-SIRPa did enhance inges-
tion. These data suggest that the SIRPa–Fgr–SHP-1 path-
way we describe here is primarily involved in regulating
other ligand–receptor pairings and is independent of
FcgRIIB-mediated suppression. This fact does bring up an
interesting question that relates to whether engagement of
SIRPa is ligand dependent. Unlike FcgRIIB, ligands for
most ITIM-containing receptors (41), including members
of the SIRP family (45), have not been identified. In this
regard, integrin-associated protein (IAP, CD47) was identi-
fied recently as a ligand for SIRPa expressed by neurons
(P84 neutral adhesion molecule [50]). Because IAP is ex-
pressed by phagocytes and regulates matrix protein–aug-
mented phagocytosis (51), it is intriguing to speculate that
phagocytic receptors associate with molecules like SIRPa and
IAP in membrane domains, and thus IAP may function as a
coreceptor for SIRPa after phagocytic receptor activation.
Two other studies have examined the effect of Fgr on
FcR-mediated phagocytosis by monocytes or macro-
phages, and both indicated that it had no effect (22, 52).
There are several reasons that may explain the discrepancy
between our results and theirs. First, both studies presumed
that Fgr would have a positive signaling role in phagocyto-
sis in these cells and assumed that ingestion would be in-
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creased in its presence. This is reasonable because Fgr is
present in high concentrations in mature phagocytes (18–
20, 25, 53) and immunoprecipitates with phagocytic recep-
tors after cell stimulation (21). Therefore, the phagocytosis
assays were done with one level of opsonin, which could
have represented such a high concentration that suppres-
sion of ingestion would have been difficult to observe (22,
52). In contrast, we examined phagocytosis over a wide
dose–response range to demonstrate differences in the level
of ingestion. In addition, the ligand on the opsonized parti-
cle affects the magnitude of the Fgr effect. For example, we
found the greatest affect in wild-type cells with IgG2a- and
C3bi-opsonized particles. Therefore, studies using poly-
clonal rabbit IgG–opsonized erythrocytes, which could
target multiple receptors, might not observe negative regu-
lation. Moreover, the work of Faulkner et al. (52) was per-
formed with the human monocytic cell line, U937, which
was transfected with human Fgr. U937 cells express FGR
endogenously (52), and therefore, ingestion may have been
suppressed constitutively such that increasing the level of
FGR by transfection would not have an effect. In addition,
we have found that the concentration of SIRPa expressed
by phagocytic cell lines can vary (Gresham, H.D., unpub-
lished observations), and SIRPa is required to observe the
negative effects of Fgr.
Our data indicate that the role of Fgr in regulating phago-
cytic responses is completely different in neutrophils than it
is in macrophages (Fig. 3). Although this result was unex-
pected, it is consistent with other data that implicate a pos-
itive signaling role for Fgr in neutrophils (53–55). Fgr exists
in intracellular granules in resting neutrophils and translo-
cates to the plasma membrane with cell activation (53). More-
over, it coimmunoprecipitates with the phagocytic receptors
FcgRIIA (54) and CR3 (55) after neutrophil activation. If
this positive signaling role for Fgr were mediated through
its kinase function, a negative signaling component could
still be contributed independently of its kinase activity
through recruitment of SHP-1. Therefore, we believe that
Fgr could have both positive and negative roles in regulat-
ing neutrophil phagocytic responses. Even in macrophages
where a negative role for Fgr was clearly demonstrated, the
magnitude of the response varied. We observed that the
source of the macrophage and cell culture conditions had a
significant effect on Fgr expression. These data confirm in
vivo observations that indicate that the level of Fgr present
in monocytic cells varies as they mature into tissue-fixed mac-
rophages (56). In fact, some macrophage populations, such
as Kupffer cells, alveolar macrophages, and Peyer’s patch
macrophages, do not express detectable levels of Fgr (56).
Intriguingly, these cells are some of the most phagocytic
cells in the reticuloendothelial system. Alternatively, expo-
sure of macrophage populations to agents like LPS or CSF-1,
which could occur at sites of inflammation or infection,
can induce the expression of Fgr (25, 56). Therefore, the
contribution of Fgr to the balance of positive and negative
signaling in phagocytosis will depend on the phagocyte, its
maturation level, its activation state, and the ligand-opsonized
target.
These data significantly extend the knowledge of Fgr bi-
ology in macrophages. Although the targeted deletion of
Fgr in combination with other Src kinases such as Hck and
Lyn has revealed significant information about the roles of
Src kinases in neutrophil and macrophage function (22,
57–59), very little has been ascertained about Fgr’s unique
role in hematopoietic cells. Therefore, our data demon-
strating an important kinase-independent role for Fgr in
negative regulation of phagocytosis are significant. While
our data do not address the possible kinase-dependent
functions of this Src kinase family member, it is intriguing
to speculate that Fgr, like Lyn (17, 47, 48), could have both
positive and negative roles in regulating hematopoietic cell
function.
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